Lantern Pharma Inc.
LTRN
$3.93
$0.133.42%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/17/2025
-
Ticker Report
2/21/2025
-
Simply Wall St
2/20/2025
-
Insider Monkey
2/20/2025
-
Insider Monkey
2/19/2025
-
GuruFocus
2/19/2025
-
Business Wire
2/10/2025
-
Ticker Report
1/27/2025
-
Insider Monkey
1/17/2025
-
Insider Monkey
1/17/2025
-
Insider Monkey
12/10/2024
-
Insider Monkey
12/10/2024
-
Insider Monkey
12/9/2024
-
The Fly
12/9/2024
-
Business Wire
12/7/2024
-
Insider Monkey
12/6/2024
-
Insider Monkey
12/3/2024
-
GuruFocus
12/3/2024
-
TipRanks Financial Blog
12/3/2024
-
The Fly
12/3/2024
-
Business Wire
11/26/2024
-
Business Wire
11/19/2024
-
The Fly
11/19/2024
-
Business Wire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 7, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 17 and 21 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 277 1136
Address
1920 McKinney Avenue
Dallas, TX 75201
Dallas, TX 75201
Country
Year Founded
Business Description
Sector
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its product...
more